Fifty years of development in the endocrinology laboratory

Clinical Biochemistry

Volumn 39, Issue 5, 2006, Pages 542-557

  Lepage, Raymond ^a   Albert, Caroline ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Array technologies; Automated analyzers; Chemiluminescence; Fluorescence; History; Non competitive immunoassays; Radioimmunoassays

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; CORTODOXONE; CYCLIC AMP; ESTRADIOL; HORMONE RECEPTOR; HYDROCORTISONE; LIOTHYRONINE; PARATHYROID HORMONE; PROGESTERONE; PROGESTERONE RECEPTOR; RENIN; TESTOSTERONE; THYROXINE;

ARTICLE; AUTOANALYZER; BIOASSAY; COLORIMETRY; ENDOCRINE FUNCTION TEST; FREE THYROXINE INDEX; HORMONE ACTION; HORMONE DETERMINATION; IMMUNOASSAY; LABORATORY; LABORATORY AUTOMATION; POINT OF CARE TESTING; PRIORITY JOURNAL;

AUTOMATION; ENDOCRINOLOGY; IMMUNOASSAY; LABORATORIES; PARATHYROID HORMONE;

EID: 33646860564     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.03.007     Document Type: Article

References (192)

1. Green J.D., and Harris G.W. The neurovascular link between the neurohypophysis and adenohypophysia. J. Endocrinol. 5 (1947) 136-146
2. Sawyer C.H., Everett J.W., and Markee J.E. A neural factor in the mechanism by which estrogen induces the release of luteinizing hormone in the rat. Endocrinology 41 (1949) 218-233
3. Guillemin R. Peptides in the brain. The new endocrinology of the neuron. In: Lindsten J. (Ed). Nobel lectures, physiology or medicine 1971-80 (1992), World Scientific Publishing Co., Singapore 364-397
4. Schally A.V. Aspects of hypothalamic regulation of the pituitary gland with major emphasis on its implications for the control of reproductive processes. In: Lindsten J. (Ed). Nobel lectures, physiology or medicine 1971-80 (1992), World Scientific Publishing Co., Singapore 405-438
5. Guillemin R., and Rosenberg B. Humoral hypothalamic control of anterior pituitary. A study with combined tissue cultures. Endocrinology 57 (1955) 599-697
6. Burgus R., Dunn T.F., Desiderio D., Ward D.N., Vale W., and Guillemin R. Characterisation of ovine hypothalamic hypophysiotropic TSH-releasing factor. Nature 226 (1970) 321-325
7. Burgus R., Butcher M., Ling N., et al. Structure moléculaire du facteur hypothalmique (LRF) d'origine ovine, contrôlant la structure et la sécrétion de l'hormone Gonadotrope Hypophysaire de Lutéinisation (LH). C. R. Acad. Sci. (Paris) 273 (1971) 1611-1613
8. Esch F.S., Bohlen P., Ling N.C., et al. Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone releasing activity. Biochem. Biophys. Res. Commun. 109 (1982) 152-158
9. Rivier J., Spiess J., Thorner M., and Vale W. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 300 (1982) 276-278
10. Vale W., Spiess J., Rivier C., and Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213 (1981) 1394-1397
11. Saffran M., and Schally A.V. The release of corticotrophin by anterior pituitary tissue in vitro. Can. J. Biochem. Physiol. 33 (1955) 408-415
12. Nair R.M.G., Barrett J.F., Bowers C.Y., and Schally A.V. Structure of porcine thyrotropin-releasing hormone. Biochemistry 9 (1970) 1103-1106
13. Matsuo H., Baba Y., Nair R.M.G., Arimura A., and Schally A.V. Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino-acid sequence. Biochem. Biophys. Res. Commun. 43 (1971) 1334-1339
14. Schally A.V., DuPont A., Arimura A., et al. Isolation and structure of growth hormone-release inhibiting hormone (somatostatin) from porcine hypothalami. Biochemistry 15 (1976) 509-514
15. Rolf L. The nobel prize in physiology or medicine 1977 (Presentation Speech). In: Lindsten J. (Ed). Nobel lectures, physiology or medicine 1971-80 (1992), World Scientific Publishing Co, Singapore
16. Langley J.N. On the contraction of muscle, chiefly in relation to the presence of "receptive" substances: Part IV. The effect of curare and of some other substances on the nicotine response of the sartorius and gastrocnemius muscles of the frog. J. Physiol. 39 (1909) 235-295
17. Erhlich P. Chemotherapeutics: scientific principles, methods and results. Lancet 2 (1913) 445-451
18. Jensen E.V., and Jacobson H.I. In: Pincus G., and Vollmer E.P. (Eds). Biological activities of steroids in relation to cancer (1960), Academic Press, New York 161-174
19. Toft D., and Gorski J. A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization. Proc. Natl. Acad. Sci. U. S. A. 57 (1966) 1574-1581
20. Jensen E.V., Suzuki T., Kawashuma T., Strumpf W.E., Jungblut P.W., and DeSombre E.R. A two-step mechanism for the interaction of estradiol with rat uterus. Proc. Natl. Acad. Sci. U. S. A. 59 (1968) 632-638
21. Green S., and Chambon P. Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor. Nature 325 (1987) 75-79
22. Giguere V., Ong E.S., Segui P., and Evans R.M. Identification of a receptor for the morphogen retinoic acid. Nature 330 (1987) 624-629
23. Pastan I., Roth J., and Macchia V. Binding of hormone to tissue: the first step in polypeptide hormone action. Proc. Natl. Acad. Sci. U. S. A. 56 (1966) 1802-1809
24. Sutherland E. Studies on the mechanism of hormone action. In: Lindsten J. (Ed). Nobel lectures, physiology or medicine 1971-80 (1992), World Scientific Publishing Co., Singapore 5-22
25. Gilman A.G. G proteins and regulation of adenylyl cyclase. In: Ringertz N. (Ed). Nobel lectures, physiology or medicine 1991-1995 (1997), World Scientific Publishing Co., Singapore 182-212
26. Rodbell M. Signal transduction: evolution of an idea. In: Ringertz N. (Ed). Nobel lectures, physiology or medicine 1991-1995 (1997), World Scientific Publishing Co., Singapore 220-237
27. Peters J.P., and Man E.W.B. The relation of albumin to precipitable iodine of serum. J. Clin. Invest. 27 (1948) 397-405
28. Heinemann J., Johnson C.E., and Man E.B. Serum precipitable iodine concentrations during pregnancy. J. Clin. Invest. 27 (1948) 91-97
29. Recant L., and Riggs D.S. Thyroid function in nephrosis. J. Clin. Invest. 31 (1952) 789-797
30. Tait J.F., and Burstein S. In vivo studies of steroid dynamics in man. In: Pincus G., Thimann K.V., and Astwood E.B. (Eds). The hormones vol. V (1964), Academic Press, New York 441-457
31. Mendel C.M., Cavalieri R.R., and Weisiger R.A. On plasma protein-mediated transport of steroid and thyroid hormones [letter]. Am. J. Physiol. 255 2 Pt. 1 (1988) E221-E224
32. Pardridge W.M. Plasma protein-mediated transport of steroid and thyroid hormones. Am. J. Physiol. 252 (1987) E157-E164
33. Ekins R. Hirsutism: free and bound testosterone [letter]. Ann. Clin. Biochem. 27 (1990) 91-93
34. Mendel C.M. The free hormone hypothesis: a physiologically based mathematical model. Endocr. Rev. 10 (1989) 232-274
35. Lepage R. Measurement of testosterone and its sub-fractions in Canada. Clin. Biochem. 39 (2006) 97-108
36. Yalow R. Radioimmunoassay. In: Lindsten J. (Ed). Nobel lectures, physiology or medicine 1971-80 (1992), World Scientific Publishing Co., Singapore 447-468
37. Mirsky I.A., Simkin B., and Broh-Kahn R.H. The inactivation of insulin by tissue extracts: VI. The existence, distribution and properties of an insulinase inhibitor. Arch. Biochem. 28 (1950) 415-423
38. Berson S.A., Yalow R.S., Bauman A., Rothschild M.A., and Newerly K. Insulin I131. Metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin-treated subjects. J. Clin. Invest. 35 (1956) 170-190
39. Yalow R.S., and Berson S.A. Assay of plasma insulin in human subjects by immunological methods. Nature 184 (1959) 1648-1649
40. Ekins R.P. The estimation of thyroxine in human plasma by an electrophoretic technique. Clin. Chim. Acta 5 (1960) 453-459
41. Murphy B.EP., Engelberg W., and Pattee C.J. Simple method for the estimation of free 11-hydroxycorticoids in human plasma. J. Clin. Pathol. 15 (1962) 374-379
42. Murphy B.E.P., and Pattee C.J. Determination of thyroxine utilizing the property of protein binding. Clin. Chim. Acta 24 (1964) 187-196
43. Demetriou J.A., and Austin F.G. Quantitation of plasma testosterone by improved competitive protein-binding technique. Clin. Chem. 16 (1970) 11-17
44. Rodbard D., Rayford P.L., Cooper J.A., and Ross G.T. Statistical quality control of radioimmunoassay. J. Clin. Endocrinol. Metab. 28 (1968) 1412-1418
45. Rodbard D., Bridson W., and Rayford P.L. Rapid calculation of radioiommunoassay results. J. Clin. Lab. Med. 74 (1969) 770-781
46. Rodbard D., and Lewald J.E. Computer analysis of radioligand assay and radioimmunoassay data. In: Diczfalusy E., and Diczfalusy A. (Eds). Steroid assay by protein binding. Karolinska Symposia on research methods in reproductive endocrinology (1970), WHO/Karolinska Institutet, Stockholm 79-98
47. Marschner I., Erhardt F., and Scriba P.C. Calculation of the radioimmunoassay standard curve by spline function. RIA and related procedures in medicine. International Atomic Energy Agency Conference Proceedings, Instanbul (1973) Sept.
48. Bolton A.E., and Hunter W.M. The labeling of proteins to high specific radioactivities by conjugation to 125I-containing acylating agent. Biochem. J. 133 (1973) 529-539
49. The chemists guide to radioassay products. Clin. Chem. 23 (1977) 405-446
50. Schall R.F., and Tenoso H.J. Alternatives to radioimmunoassay: labels and methods. Clin. Chem. 27 (1981) 1157-1164
51. Wide L., Bennich H., and Johansson S.G.O. Diagnosis of allergy by an in-vitro test for allergen antibodies. Lancet 2 (1967) 1105-1107
52. Miles L.E.H., and Hales C.N. An immunoradiometric assay of insulin. In: Margoulies M. (Ed). Protein and polypeptide hormone: Part 1 (1968), Excerpta Medica, Amsterdam 61-70
53. Köhler G., and Milstein C. Continuous culture of fused cells secreting antibody of predefined specificity. Nature 256 (1975) 495-497
54. Wisdom G.B. Enzyme-immunoassay. Clin. Chem. 22 (1976) 1243-1255
55. Rodbard D., and Weiss G.H. Mathematical theory of immunometric [labeled antibody] assay. Anal. Biochem. 52 (1973) 10-44
56. Ekins R. Immunoassay and other ligand assays: from isotopes to luminescence. J. Ligand Assay 22 (1999) 61-77
57. Ekins R., and Edwards P. On the meaning of sensitivity. Clin. Chem. 43 (1997) 1824-1831
58. Pardue H.L. The inseparable triad: analytical sensitivity, measurement uncertainty, and quantitative resolution. Clin. Chem. 43 (1997) 1831-1837
59. Ekins R., and Edwards P. On the meaning of sensitivity: a rejoinder. [Letter]. Clin. Chem. 44 (1998) 1773-1775
60. Pardue H.L. On the meaning of sensitivity: a rejoinder. [Letter]. Clin. Chem. 44 (1998) 1776-1778
61. International vocabulary of basic and general terms in metrology. Switzerland international organization for standardization. 2nd ed. (1993) ISBN 92-67-01075
62. Dybkaer P. Vocabulary for use in measurement procedures and description of reference materials in laboratory medicine. Eur. J. Clin. Chem. Clin. Biochem. 35 (1997) 141-173
63. Ekins R.P., Newman B., and O'Riordan J.L.H. Saturation assays. In: McArthur J.W., and Colton T. (Eds). Statistics in endocrinology (1970), MIT Press, Cambridge, MA 345-378
64. Ekins R.P. Ligand assays: from electrophoresis to miniaturized microarrays. Clin. Chem. 44 (1998) 2015-2030
65. Andrieu J.M., Manas S., and Dray F. Viroimmunoassay of steroids: methods and principles. In: Cameron E.H.D., Hiller S.G., and Griffiths K. (Eds). Steroid immunoassay. Proceedings of the 5th Tenovus Workshop, Cardif, April 1974 (1975), Alpha Omega Publishing, Cardif 189-198
66. Pratt J.J., Woldring M.G., and Villerius L. Chemiluminescence-linked immunoassay. J. Immunol. Methods 21 (1978) 179-184
67. Schroeder H.R., Yeager F.M., Bogulaski R.C., Snoke E.O., and Buckler R.T. Immunoassay for thyroxine monitored by chemiluminescence. Clin. Chem. 23 (1977) 1132 [Abstract]
68. Kobayashi Y., Amitani K., Watanabe F., and Miyai K. Fluorescence polarization immunoassay for cortisol. Clin. Chim. Acta 92 (1979) 241-247
69. Smith D.S. Enhancement fluoroimmunoassay of thyroxine. FEBS Lett. 77 (1977) 25-27
70. Leuvering J.H., Thal P.J., Van der Waart M., and Schuurs A.H. A sol particle agglutination assay for human chorionic gonadotropin. J. Immunol. Methods 45 (1981) 183-194
71. Cambiaso C.L., Leek A.E., de Steenwinkel F., Billen J., and Masson P.L. Particle counting immunoassay (PACIA): I. A general method for the determination of antibodies, antigens, and haptens. J. Immunol. Methods 18 (1977) 33-44
72. Von Schultness G.K., Giglio M., Cannell D.S., and Benedek G.B. Detection of agglutination reactions using anisotropic light scattering: an immunoassay of high sensitivity. Molec. Immunol. 17 (1980) 81-92
73. Tan C.T., Chan S.W., and Hsia J.C. Membrane immunoassay: a spin membrane immunoassay for thyroxine. Methods Enzymol. 74 (1981) 152-161
74. M. Cais, Specific binding assay method and reagent means. U.S. Patent No 4,205,952 (1980).
75. Wei R., and Almirez R. Spin immunoassay of progesterone. Biochem. Biophys. Res. Commun. 62 (1975) 510-516
76. Sayo H., and Hosokawa M. Spin immunoassay of urinary testosterone. Yakaguchi Zashi 100 (1980) 56-60
77. Kricka L.J., and Thorpe G.H.G. Luminescent immunoassays. [Review]. Ligand Rev. 3 (1981) 17-24
78. Schroeder H.R., Yeager F.M., Bogulaski R.C., Snoke E.O., and Buckler R.T. Immunoassay for thyroxine monitored by chemiluminescence. Clin. Chem. 23 (1977) 1132 [Abstract]
79. Pratt J.J., Woldring M.G., and Villerius L. Chemiluminescence-linked immunoassay. J. Immunol. Methods 21 (1978) 179-184
80. F. McCapra, R.E. Tutt, R.M. Topping, Assay method utilizing chemiluminescence. US Patent 1,461,877 (1977).
81. Bronstein I., Edwards B., and Vayta J.C. 1,2-Dioxetanes: novel chemiluminescent enzyme substrates. J. Biolumin. 4 (1990) 88-111
82. Arakawa H., Maeda M., and Tsuji A. A chemiluminescence enzyme immunoassay of cortisol using peroxidase as a label. Anal. Biochem. 97 (1979) 248-254
83. Thorpe G.H.G., and Kricka L.J. Enhanced chemiluminescence enzyme immunoassays. In: Collins W.P. (Ed). Complementary immunoassays (1988), Wiley, Chichester 169-179
84. Blackburn G.F., Shah H.P., Kenten J.H., et al. Electrochemiluminescence detection for development of immunoassays and DNA probe assays for clinical diagnostics. Clin. Chem. 37 (1991) 1534-1539
85. Christopoulos T.K., and Diamandis E.P. Fluorescence immunoassays. In: Diamandis E.P., and Christopoulos T.K. (Eds). Immunoassay (1996), Academic Press, San Diego 309-335
86. Aalberse R.C. Quantitative fluoroimmunoassay. Clin. Chim. Acta 48 (1973) 109-111
87. Soini E., and Hemmilä I. Fluoroimmunoassay: present status and key problems. Clin. Chem. 25 (1979) 353-361
88. Kominami G., Fujiswaka I., Yamauchi A., and Kono M. A sensitive enzyme immunoassay for plasma cortisol. Clin. Chim. Acta 103 (1980) 381-391
89. Dandliker W.B., and Feigen G.A. Quantification of the antigen-antibody reaction by the polarization of fluorescence. Biochem. Biophys. Res. Commun. 5 (1961) 299-304
90. Dandliker W.B., Shapiro H.C., Meduski J.W., Alonso R., and Feigen G.A. Application of fluorescence polarization to the antigen-antibody reaction. Theory and experimental method. Immunochemistry 1 (1964) 165-191
91. Marshall N.J., Dakubu S., Jackson T., and Ekins R.P. Pulsed light, time resolved fluoroimmuoassay. In: Albertini A., and Ekins R.P. (Eds). Monoclonal antibodies and developments in immunoassay (1981), Elsevier, Amsterdam 101-108
92. Christopoulos T.K., and Diamandis E.P. Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates. Anal. Chem. 64 (1992) 342-346
93. Diamandis E.P. Signal amplification in time-resolved fluorometry. Clin. Chem. 47 (2001) 380-381
94. Morton R.C., and Diamandis E.P. Streptavidin-based macromolecular complex labeled with a europium chelator suitable for time-resolved fluorescence immunoassay applications. Anal. Chem. 62 (1990) 1841-1845
95. Scoulas A., and Diamandis E.P. Polyvinylamine-streptavidin complexed labeled with a europium chelator: a universal detection reagent for solid-phase time resolved fluorometric applications. Clin. Biochem. 33 (2000) 345-350
96. Harma H., Soukka T., and Longren T. Europium nanoparticles and time-resolved fluorescence for ultrasensitive detection of prostate specific antigen. Clin. Chem. 47 (2001) 561-568
97. Bayer E.A., and Wilchek M. The avidin-biotin complex as a tool in molecular biology. Trends Biochem. Sci. 3 (1978) N237-N239
98. Bayer E.A., and Wilchek M. The avidin-biotin system. In: Diamandis E.P., and Christopoulos T.K. (Eds). Immunoassay (1996), Academic Press, San Diego 237-267
99. Catt K., and Treggar G.W. Solid-phase radioimmunoassay in antibody-coated tubes. Science 158 (1967) 1570-1572
100. Butler J.E. Solid phases in immunoassay. In: Diamandis E.P., and Christopoulos T.K. (Eds). Immunoassay (1996), Academic Press, San Diego 205-226
101. Spencer C.A., and Challand G.S. Interference in a radioimmunoassay for human thyrotropin. Clin. Chem. 23 (1977) 584-588
102. Imagawa M., Ishikawa E., Yoshitake S., et al. A sensitive and specific sandwich enzyme immunoassay for human thyroid stimulating hormone. Clin. Chim. Acta 126 (1982) 227-236
103. Weeks I., Sturgess M., Siddle K., Jones M.K., and Woodhead J.S. A high sensitivity immunochemiluminometric assay for human thyrotropin. Clin. Endocrinol. 20 (1984) 489-495
104. Lövgren T., Hemmilä I., Petterson K., Eskola J.U., and Bertott E. Determination of hormones by time-resolved fluoroimmunoassay. Talanta 31 (1984) 909-916
105. Baret A., and Fert V. T4 and ultrasensitive TSH immunoassays using luminescent enhanced xanthine oxidase assay. J. Biolumin. Chemilumin. 4 (1990) 149-153
106. Papanastasiou-Diamandi A., Christopoulos T.K., and Diamandis E.P. Ultrasensitive thyrotropin immunoassay based on enzymatically amplified time-resolved fluorescence with terbium-chelates. Clin. Chem. 38 (1992) 545-548
107. Hay I.D., Bayer M.F., Kaplan M.M., Klee G.G., Larsen P.R., and Spencer C.A. American thyroid association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays. Clin. Chem. 37 (1991) 2002-2008
108. Caldwell G., Kellett H.A., Gow S.M., et al. A new strategy for thyroid function testing. Lancet 1 (1985) 1117-1119
109. Sterling K., and Hegedus A. Measurement of free thyroxine concentration in human serum. J. Clin. Invest. 41 (1962) 1031-1040
110. Ekins R., Filette S., Kurtz A.B., and Dwyer K. A simple method for the assay of free hormones (and drugs): its application to the measurement of serum free thyroxine levels and the bearing of assay results on the "free thyroxine" concept. J. Endocrinol. 85 (1980) 29-30
111. Wilkins T.A., and Midgley J.E.M. New methods of free thyroid hormone assay. In: Bizollon C.A. (Ed). Physiological peptides and new trends in radioimmunology (1981), Elsevier Biomedical Press, Amsterdam 215-234
112. Sheehan C.P., and Christofides N.D. One-step, labeled-antibody assay for measuring free thyroxin. Performance in a multicenter trial. Clin. Chem. 38 (1992) 19-25
113. Free thyroxine (FT4) and free triiodothyronine (FT3) tests. In: Demers L., and Spencer C.A. (Eds). Laboratory support for the diagnosis and monitoring of thyroid disease (2002) 20-32 [NACB]
114. Alexander N.M. Free thyroxin in serum: labeled thyroxin analog methods fall short of their mark. [Editorial]. Clin. Chem. 32 (1986) 417
115. Ekins R. Measurement of free hormones in blood. [Review]. Endocr. Rev. 11 (1990) 5-46
116. Wilke T.J. Estimation of free thyroid hormone concentrations in the clinical laboratory. [Review]. Clin. Chem. 32 (1986) 585-592
117. Cheng R.W., Reed M.J., and James V.H. Plasma free testosterone: equilibrium dialysis vs direct radioimmunoassay. Clin. Biochem. 31 (1998) 15-21
118. Winters S.J., Kelley D.E., and Goodpaster B. The analog free testosterone assay: are results in men clinically useful?. Clin. Chem. 44 (1988) 2178-2182
119. Miller K.K., Rosner W., Lee H., et al. Measurement of free testosterone in normal women and women with androgen deficiency. J. Clin. Endocrinol. Metab. 89 (2004) 525-533
120. Davies B.M., Gordon A.H., and Mussett M.V. A plasma calcium assay for parathyroid hormone, using parathyroidectomized rats. J. Physiol. 125 (1954) 383-395
121. Davies B.M., Gordon A.H., and Mussett M.V. A mouse urine phosphate assay for parathyroid hormone, with certain applications. J. Physiol. 130 (1955) 79-95
122. Berson S.A., Yalow R.S., Aurbach G.D., and Potts Jr. J.T. Immunoassay of bovine and human parathyroid hormone. Proc. Natl. Acad. Sci. U. S. A. 49 (1963) 613-617
123. Berson S.A., and Yalow R.S. Immunological heterogeneity of parathyroid hormone in plasma. J. Clin. Endocrinol. Metab. 28 (1968) 1037-1047
124. Keutmann H.T., Sauer M.M., Hendy G.N., O'Riordan J.H.L., and Potts Jr. J.T. Complete amino acid sequence of human parathyroid hormone. Biochemistry 17 (1978) 5723-5729
125. Brewer Jr. H.B., and Ronan R. Bovine parathyroid hormone: amino acid sequence. Proc. Natl. Acad. Sci. U. S. A. 67 (1970) 1862-1869
126. Aurbach G.D., and Houston B.A. Determination of 3′,5′-adenosine monophosphate with a method based on a radioactive phosphate exchange reaction. J. Biol. Chem. 243 (1968) 5935-5940
127. Potts Jr. J.T., Tregear G.W., Keutmann H.T., et al. Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone. Proc. Natl. Acad. Sci. U. S. A. 68 (1971) 63-67
128. Tregear G.W., van Rietschoten J., Greene E., et al. Solid-phase synthesis of the biologically active N-terminal 1-34 peptide human parathyroid hormone. Hoppe-Seyler Z. physiol. Chem. 355 (1974) 415-421
129. Gao P., and D'Amour P. Evolution of the parathyroid hormone (PTH) assay. Importance of circulating PTH immunoheterogeneicity and its regulation. Clin. Lab. 51 (2005) 21-29
130. Elder G. Pathophysiology and recent advances in the management of renal osteodystrophy. J. Bone Miner. Res. 17 (2002) 2094-2105
131. D'Amour P., and Brossard J.H. Carboxyl-terminal parathyroid hormone fragments role in parathyroid hormone physiopathology. Curr. Opin. Nephrol. Hypertens. 14 (2005) 330-336
132. Lufkin E.G., Kao P.G., and Heath H. Parathyroid hormone radioimmunoassays in differential diagnosis of hypercalcemia due to primary hyperparathyroidism or malignancy. Ann. Intern. Med. 106 (1987) 559-560
133. Brossard J.H., Whittom S., Lepage R., and D'Amour P. Carboxyl-terminal fragments of parathyroid hormone are not secreted preferentially in primary hyperparathyroidism as they are in other hypercalcemic conditions. J. Clin. Endocrinol. Metab. 77 (1993) 413-419
134. D'Amour P. Effects of acute and chronic hypercalcemia on parathyroid function and circulating parathyroid hormone molecular forms. Eur. J. Endocrinol. 148 (2002) 407-410
135. Andress D.L., Endress D.B., Maloney N.A., Kopp J.B., Coburn J.W., and Sherrard D.J. Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy. J. Clin. Endocrinol. Metab. 63 (1986) 1163-1169
136. Nussbaum S.R., Zahradnik R.J., Lavigne J.R., et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin. Chem. 33 (1987) 1364-1367
137. Ratcliffe W.A., Heath D.A., Ryan M., and Jones S.R. Performance and diagnostic application of two-site immunoradiometric assay for parathyrin in serum. Clin. Chem. 35 (1989) 1957-1961
138. Felsenfeld A.J., and Liach F. Parathyroid gland function in chronic renal failure. Kidney Int. 43 (1993) 771-789
139. Brossard J.H., Cloutier M., Roy L., Lepage R., Gascon-Barre M., and D'Amour P. Accumulation of non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact assay in renal failure: importance in the interpretation of PTH values. J. Clin. Endocrinol. Metab. 81 (1996) 3923-3929
140. Lepage R., Roy L., Brossard J.H., et al. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin. Chem. 44 (1998) 805-809
141. D'Amour P., Brossard J.H., Rousseau L., Nguyen-Yamamoto L., Nassif E., Lazure C., et al. Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism. Kidney Int. 68 (2005) 998-1007
142. Nguyen-Yamamoto L., Rousseau L., Brossard J.H., Lepage R., and D'Amour P. Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different form the PTH/PTH related peptide receptor. Endocrinology 142 (2001) 1386-1392
143. Murray T.M., Rao L.G., Divieti P., and Bringhurst R.F. Parathyroid hormone secretion and action: evidence for discrete receptors for carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocr. Rev. 26 (2005) 78-113
144. Salusky I.B., Goodman W.G., Kuizon B.D., et al. Similar predictive value of bone turnover using first and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney Int. 63 (2003) 1801-1808
145. Monier-Faugere M.C., Geng Z., Mawad H., et al. Improved assessment of bone turn-over by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int. 60 (2001) 1460-1468
146. Takamoto A. Superior assessment of bone turnover in ESRD patients by the 1-84 PTH/large C-terminal PTH fragments ratio. A bone biopsy study. J. Am. Soc. Nephrol. 14 (2003) 702 [Abstract]
147. Coen G., Bonucci E., Ballanti P., et al. PTH 1-84 and "7-84" in non invasive diagnosis of renal bone disease. Am. J. Kidney Dis. 40 (2002) 348-354
148. D'Amour P., Brossard J.H., Rousseau L., Roy L., Gao P., and Cantor T. Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidism. Clin. Chem. 49 (2003) 2037-2044
149. Rakel A., Brossard J.H., Patenaude J.V., et al. Overproduction of amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery. Clin. Endocrinol. 62 (2005) 721-727
150. Pollard S., and Waldron C.B. Automatic radioimmunoassay. In: Kwerau E., et al. (Ed). Automation in analytical chemistry, Technicon Symposia in analytical chemistry. Technicon Symposia 1966 (1967), Mediad Inc., White Plains, NY 49
151. Ismail A.A., West P.M., and Goldie D.J. The «Southmead System», a simple, fully automated, continuous flow system for immunoassays. [Appendix: Application to serum thyroxine radioimmunoassay]. Clin. Chem. 24 (1978) 571-579
152. Luner S.J. Continuous flow automated radioimmunoassay using antibodies attached to red blood cells. Anal. Biochem. 65 (1975) 355-361
153. Nye L., Forrest G.C., and Greenwood H. Solid-phase magnetic particle radioimmunoassay. Clin. Chim. Acta 69 (1976) 387-396
154. Welshman S.G., McMaster M.D., and Linton T. Evaluation of the Technicon Star system for the estimation of serum T4 and T3-uptake. Automated Methods and Mgt in Chemistry 3 (1981) 201-203
155. Ertinghausen G., Shapiro S.I., Green G., and Zhorowsski G. Adaptation of T3-uptake test and of radioimmunoassays for serum digoxin, thyroxine and triiodothyronine to an automated radioimmunoassay system. Clin. Chem. 21 (1975) 1305-1313
156. Johnson E.G., and Stonecypher T.E. Development of Micromedic Systems' "Concept 4 Automatic Radioassay System". Clin. Chem. 22 (1976) 1164 [Abstract]
157. Brooker G., Terasaki W.L., and Price M.G. Gammaflow: a completely automated radioimmunoassay system. Science 194 (1976) 270-276
158. L.R. Johnson, Method and apparatus for radioimmunoassay with regeneration of immunoabsorbent. U.S. Patent no 3,896,217 (1975).
159. Popelka S.R., Miller D.M., Hlen J.T., and Kelso D.M. Fluorescence polarization immunoassay: II. Analyzer for rapid, precise measurement of fluorescence polarization with use of disposable cuvettes. Clin. Chem. 27 (1981) 1198-1201
160. Rubenstein K.E., Schneider R.S., and Ullman E.F. "Homogeneous" enzyme immunoassay. A new immunochemical technique. Biochem. Biophys. Res. Commun. 47 (1972) 846-851
161. Ullman E.F., Blakemore J., Leute R.K., Eimstad W., and Jaklitsch A. Homogenous enzyme immunoassay for thyroxine. Clin. Chem. 21 (1975) 1101 [Abstract]
162. Giegel J.L., Brotherton M.M., Cronin P., et al. Radial partition immunoassay. Clin. Chem. 28 (1982) 1894-1898
163. Rogers L.C., Kahn S.E., Oeser T.H., and Bermes Jr. E.W. The Stratus immunofluorometric assay system evaluated for measuring serum cortisol. Clin. Chem. 32 (1986) 1588
164. Flore M., Mitchell J., Doan R., et al. The Abbott IMx automated benchtop immunochemistry analyzer system. Clin. Chem. 34 (1988) 1726-1732
165. Boland J., Carey G., Krodel E., and Kwiatkowaki M. The Ciba Corning ACS:180 benchtop immunoassay analyzer. Clin. Chem. 36 (1990) 1598-1602
166. Ford A. Automated immunoassay analyzers: the latest lineup. Cap. Today (2004) 18-57
167. Cole L.A., and Khanlian S.A. Easy fix for clinical laboratories for the false-positive defect with the Abbott AxSym total beta-hCG test. Clin. Biochem. 37 (2004) 344-349
168. Diamandis E.P. Immunoassay interference: a relatively rare but still important problem. Clin. Biochem. 37 (2004) 331-332
169. Fahie-Wilson M.N. Detection of macroprolactin causing hyperprolactinemia in commercial assays for prolactin. [Letter]. Clin. Chem. 46 (2000) 2022-2023
170. Suliman A.M., Smith T.P., Gibney J., and McKenna T.J. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clin. Chem. 49 (2003) 1504-1509
171. Stanczyk F.Z., Cho M.M., Endres D.B., Morrison J.L., Patel S., and Paulson R.J. Limitations of direct estradiol and testosterone immunoassay kits. Steroids 68 (2003) 1173-1178
172. Murphy B.E. How much "UFC" is really cortisol?. [Editorial]. Clin. Chem. 46 (2000) 793-794
173. Binkley N., Krueger D., Cowgill C.S., et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J. Clin. Endocrinol. Metab. 89 (2004) 3152-3157
174. Kricka L.J. Human anti-animal antibody interferences in immunological assays. Clin. Chem. 45 (1999) 942-956
175. Levinson S.S., and Miller J.J. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin. Chim. Acta 325 (2002) 1-15
176. Galen R.S., and Gambino R.S. Beyond normality : the predictive value and efficiency of medical diagnosis (1975), John Wiley and Sons, New York
177. Koch D.D., and Peters Jr. T. Selection and evaluation of methods. In: Burtis C.A., and Ashwood E.R. (Eds). Tietz Textbook of Clinical Chemistry. 3rd ed. (1999), WB Saunders and Co., Singapore 320-335
178. Volosov A., Napoli K.L., and Soldin S.J. Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography-tandem mass spectrometry. Clin. Biochem. 34 (2001) 285-290
179. Nussbaum S.R., Thompson A.R., Hutcheson B.A., Gaz R.D., and Wang C. Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery 104 (1988) 1121-1127
180. Wians Jr. F.H. Intraoperative parathyroid hormone testing: a revolution in point-of-surgery testing on the horizon?. Clin. Biochem. 33 (2000) 501-503
181. Sokoll L.J., Wians F.H., and Remaley A.T. Rapid intraoperative immunoassay of parathyroid hormone and other hormones: a new paradigm for point-of-care testing. Clin. Chem. 50 (2004) 1126-1135
182. Woods J.M., Sampson M.L., and Remaley A.T. Rapid intraoperative cortisol assay: design and utility for localizing adrenal tumors by venous sampling. Clin. Biochem. 33 (2000) 501-503
183. Albright S.V., McCart J.A., Libutti S.K., et al. Development of a rapid intraoperative immunoassay for insulin. Ann. Clin. Biochem. 39 (2002) 513-515
184. Valdemarsson S., Ljunggren S., Cervin A., et al. Evaluation of surgery for acromegaly: role of intraoperative growth hormone measurement?. Scand. J. Clin. Lab. Invest. 61 (2001) 459-470
185. Czirjak S., Bezzegh A., Gal A., and Racz K. Intra- and postoperative plasma ACTH concentrations in patients with Cushing's disease cured by transsphenoidal pituitary surgery. Acta Neurochir. (Wien) 144 (2002) 971-977
186. Proye C., Pattou F., Carnaille B., Paris J.C., d'Herbomez M., and Marchandise X. Intraoperative gastrin measurements during surgical management of patients with gastrinomas: experience with 20 cases. World J. Surg. 22 (1998) 643-649
187. Eng C. Seminars in Medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschprung's disease. N. Engl. J. Med. 335 (1996) 943-951
188. Nordenstrom A., Thilen A., Hagenfelt L., Larsson A., and Wedell A. Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 84 (1999) 1505-1509
189. Ringel M.D., Ladenson P.W., and Levine M.A. Molecular diagnosis of residual or recurrent thyroid cancer by amplification of thyroglobulin mRNA in peripheral blood. J. Clin. Endocrinol. Metab. 83 (1988) 4435-4442
190. Diamandis E.P., and Youssef G.M. Human tissue kallikrein gene family: a rich source of novel disease biomarkers. Exper. Rev. Mol. Diagn. 1 (2001) 182-190
191. Herynk M.H., and Fuqua S.A. Estrogen receptor mutations in human disease. Endocr. Rev. (2004) 869-898
192. Fitzgerald S.T., Lamont J.V., McConnell R.I., and Benchick E.O. Development of a high-throughput automated analyzer using biochip array technology. Clin. Chem. 51 (2005) 1165-1176